Clinical Practice Session

Contrast-Associated AKI: Does It Exist and What Should We Tell Patients?

November 09, 2019 | 10:30 AM - 12:30 PM

Location: Ballroom B, Walter E. Washington Convention Center

Session Description

Patients with underlying kidney diseases are often given conflicting information about nephrotoxic contrast risk when they require contrast-based imaging. This is based on recent data, primarily from the radiology literature, that suggest contrast-associated AKI is overestimated or nonexistent. However, other data suggest that contrast-associated AKI is a real clinical problem, particularly in patients with underlying risk factors. Potential mechanisms of contrast-associated AKI and interventions to prevent injury are reviewed.

Learning Objective(s)

  • Discuss the controversy concerning the role of contrast in causing AKI
  • Summarize new data on potential mechanisms of contrast-associated AKI
  • Describe the effective interventions to reduce contrast-associated kidney diseases

Learning Pathway(s)

  • Acute Kidney Injury
  • Cell and Transport Physiology

Moderators

  • Kevin W. Finkel, MD, FASN
  • Amy W. Williams, MD

Presentations

  • Contrast Does Not Cause AKI
    10:30 AM - 11:00 AM
    Jennifer McDonald, PhD
  • Contrast Is Associated with AKI
    11:00 AM - 11:30 AM
    Glenn Matthew Chertow, MD, FASN, MPH
  • Interventions to Prevent Contrast-Associated AKI
    11:30 AM - 12:00 PM
    Steven D. Weisbord, MD, FASN
  • Potential Mechanisms Underlying Contrast-Associated AKI
    12:00 PM - 12:30 PM
    Daniel A. Muruve, MD